The effect of methamphetamine on an animal model of erectile function

Andrology

Volumn 2, Issue 4, 2014, Pages 531-536

  Tar, M T ^a   Martinez, L R ^b   Nosanchuk, J D ^a   Davies, K P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

Author keywords

Erectile dysfunction; Methamphetamine; Rat model; Tadalalfil

Indexed keywords

METHAMPHETAMINE; TADALAFIL; CARBOLINE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG MEGADOSE; ERECTILE DYSFUNCTION; MALE; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RAT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; SPRAGUE DAWLEY RAT;

ANIMALS; CARBOLINES; DISEASE MODELS, ANIMAL; ERECTILE DYSFUNCTION; MALE; METHAMPHETAMINE; PENILE ERECTION; PHOSPHODIESTERASE 5 INHIBITORS; RATS, SPRAGUE-DAWLEY;

EID: 84904595154     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/j.2047-2927.2014.00212.x     Document Type: Article

References (26)

1. Altman AL, Seftel AD, Brown SL & Hampel N. (1999) Cocaine associated priapism. J Urol 161, 1817-1818.
2. Bang-Ping J. (2009) Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med 6, 1072-1080.
3. Bernabe J, Rampin O, Sachs BD & Giuliano F. (1999) Intracavernous pressure during erection in rats: an integrative approach based on telemetric recording. Am J Physiol 276, R441-R449.
4. Broadley KJ. (2010) The vascular effects of trace amines and amphetamines. Pharmacol Ther 125, 363-375.
5. Christ GJ, Andersson KE, Williams K, Zhao W, D'Agostino R, Jr, Kaplan J et al. (2009) Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol 56, 1055-1066.
6. Cregler LL & Mark H. (1986) Medical complications of cocaine abuse. N Engl J Med 315, 1495-1500.
7. Davies KP, Tar M, Rougeot C & Melman A. (2007) Sialorphin (the mature peptide product of Vcsa1) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat. BJU Int 99, 431-435.
8. Dean RC & Lue TF. (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 32, 379-395, v.
9. Gonzales R, Mooney L & Rawson RA. (2010) The methamphetamine problem in the United States. Annu Rev Public Health 31, 385-398.
10. Heal DJ, Smith SL, Gosden J & Nutt DJ. (2013) Amphetamine, past and present-a pharmacological and clinical perspective. J Psychopharmacol 27, 479-496.
11. Islam MN, Kuroki H, Hongcheng B, Ogura Y, Kawaguchi N, Onishi S et al. (1995) Cardiac lesions and their reversibility after long term administration of methamphetamine. Forensic Sci Int 75, 29-43.
12. Kendirci M, Pradhan L, Trost L, Gur S, Chandra S, Agrawal KC et al. (2007) Peripheral mechanisms of erectile dysfunction in a rat model of chronic cocaine use. Eur Urol 52, 555-563.
13. Lee JH, Oh JH & Lee YJ. (2013) Simple and sensitive liquid chromatography-tandem mass spectrometry methods for quantification of tadalafil in rat plasma: application to pharmacokinetic study in rats. Arch Pharm Res 36, 457-463.
14. Legge D & Steinberg H. (1962) Actions of a mixture of amphetamine and a barbiturate in man. Br J Pharmacol Chemother 18, 490-500.
15. Mansergh G, Shouse RL, Marks G, Guzman R, Rader M, Buchbinder S et al. (2006) Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 82, 131-134.
16. Melman A, Zotova E, Kim M, Arezzo J, Davies K, DiSanto M et al. (2009) Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats. BJU Int 104, 1292-1300.
17. Moreland RB, Hsieh G, Nakane M & Brioni JD. (2001) The biochemical and neurologic basis for the treatment of male erectile dysfunction. J Pharmacol Exp Ther 296, 225-234.
18. Munarriz R, Hwang J, Goldstein I, Traish AM & Kim NN. (2003) Cocaine and ephedrine-induced priapism: case reports and investigation of potential adrenergic mechanisms. Urology 62, 187-192.
19. Prestage G, Jin F, Kippax S, Zablotska I, Imrie J & Grulich A. (2009) Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. J Sex Med 6, 2311-2320.
20. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al. (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39, 32-41.
21. Sugimoto K, Okamura K, Tanaka H, Takashima S, Ochi H, Yamamoto T et al. (2009) Methamphetamine directly accelerates beating rate in cardiomyocytes by increasing Ca(2+) entry via L-type Ca(2+) channel. Biochem Biophys Res Commun 390, 1214-1220.
22. Sulzer D, Sonders MS, Poulsen NW & Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75, 406-433.
23. Thompson CA. (2008) Pulmonary arterial hypertension seen in methamphetamine abusers. Am J Health Syst Pharm 65, 1109-1110.
24. Waldkirch E, Uckert S, Yildirim H, Sohn M, Jonas U, Stief CG et al. (2005) Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries-immunohistochemical distribution and functional significance. World J Urol 23, 405-410.
25. Wang YJ, Chan MH & Chen HH. (2013) Methamphetamine inhibits voltage-gated potassium currents in NG108-15 cells: possible contribution to large-conductance calcium-activated potassium channels. Toxicol Lett 223, 139-145.
26. Werner ME, Zvara P, Meredith AL, Aldrich RW & Nelson MT. (2005) Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel. J Physiol 567, 545-556.